Richard Unwin

Founder at Complement Therapeutics

Richard leads research programmes in Manchester studying protein levels in a range of human diseases, including AMD, identifying novel disease pathways, markers and therapeutic targets.

Timeline

  • Founder

    Current role

  • Founder & Acting CTO